🔥🐔 BizChicken 🐔🔥

Companies Similar to Astria Therapeutics, Inc.

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Athira Pharma, Inc.

Athira Pharma, Inc. logo
Market Cap: Lowest
Employees: Low

ATH-1017

Athira Pharma, Inc. is a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, with its lead product, ATH-1017, in clinical trials for Alzheimer's and Parkinson's diseases.

Tags: Alzheimer's disease, Parkinson's disease, biopharmaceutical, clinical trials, neurodegeneration

Symbol: ATHA

Recent Price: $0.55

Industry: Biotechnology

CEO: Dr. Mark J. Litton M.B.A., Ph.D.

Sector: Healthcare

Employees: 65

Address: 18706 North Creek Parkway, Bothell, WA 98011

Phone: 425 620 8501

Last updated: 2024-12-31

Allarity Therapeutics, Inc.

Allarity Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

Stenoparib, Dovitinib, IXEMPRA, Li Pla Cis, 2X-111

Allarity Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing oncology therapeutics using companion diagnostics and drug response predictor technology.

Tags: biopharmaceutical, clinical trials, companion diagnostics, oncology, therapeutics

Symbol: ALLR

Recent Price: $1.12

Industry: Biotechnology

CEO: Mr. Thomas H. Jensen

Sector: Healthcare

Employees: 5

Address: 210 Broadway, Cambridge, MA 02139

Phone: 401 426 4664

Last updated: 2024-12-31

Applied Therapeutics, Inc.

Applied Therapeutics, Inc. logo
Market Cap: Medium
Employees: Lowest

AT-007

Applied Therapeutics, Inc., a biopharmaceutical company, develops novel products targeting cardiovascular disease, galactosemia, and diabetic complications. Key products include AT-007 and AT-001.

Tags: biopharmaceutical, cardiovascular disease, clinical trials, diabetic complications, galactosemia

Symbol: APLT

Recent Price: $0.81

Industry: Biotechnology

CEO: Dr. Shoshana Shendelman Ph.D.

Sector: Healthcare

Employees: 31

Address: 545 Fifth Avenue, New York, NY 10017

Phone: 212 220 9226

Leadership

  • Shoshana Shendelman, Chair, Board of Directors
  • Riccardo Perfetti, Chief Medical Officer
  • Les Funtleyder,
  • Dale Hooks, Chief Commercial Officer
  • Constantine Chinoporos, Chief Business Officer / Chief Operating Officer
  • Joel Marcus,
  • Jay Skyler,
  • Stacy Kanter,
  • Teena Lerner,
  • Donald Landry M.D., Ph.D., Chair, Scientific Advisory Board
  • Roy Freeman M.D.,
  • Roxana Mehran M.D.,
  • Lawrence Steinman M.D.,
  • Gregg Stone M.D.,
  • Donald d'Amico M.D.,
  • Donald Landry, Chair, Scientific Advisory Board
  • Roy Freeman,
  • Roxana Mehran,
  • Lawrence Steinman,
  • Gregg Stone,
  • Donald d'Amico,

Last updated: 2024-12-31

Lyra Therapeutics, Inc.

Lyra Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Low

XTreo technology platform

Lyra Therapeutics, Inc. is a clinical-stage therapeutics company developing integrated drug and delivery solutions for ear, nose, and throat diseases using its XTreo technology platform. It focuses on product candidates like LYR-210 and LYR-220 for chronic rhinosinusitis.

Tags: biotechnology, chronic rhinosinusitis, drug delivery, healthcare, therapeutics

Symbol: LYRA

Recent Price: $0.22

Industry: Biotechnology

CEO: Dr. Maria Palasis Ph.D.

Sector: Healthcare

Employees: 88

Address: 480 Arsenal Way, Watertown, MA 02472

Phone: 617 393 4600

Leadership

  • Harlan W. Waksal, M.D., Executive Chairman
  • Maria Palasis, Ph.D., President and Chief Executive Officer
  • Jason Cavalier, Chief Financial Officer
  • Robert Kern, M.D., Chief Clinical Advisor
  • Ronan O’Brien, Chief Legal Officer
  • Vineeta Belanger, Ph.D., Senior Vice President of Clinical Affairs
  • Gloria Cosgrove, Senior Vice President of Quality
  • Allison Nance, Senior Vice President of Regulatory Affairs
  • Michael Altman, CFA, Managing Director, Perceptive Advisors
  • Ann Merrifield, Life Sciences Advisor and Board Director
  • Konstantin Poukalov, Managing Director, Perceptive Advisors
  • Bradford Smith, Board Director
  • Nancy L. Snyderman, M.D., Board Director
  • Jim Tobin, Lead Independent Director
  • Robert Langer, D.Sc., David H. Koch Institute Professor, Massachusetts Institute of Technology
  • George Whitesides, Ph.D., Woodford L. and Ann A. Flowers University Professor, Harvard University

Last updated: 2024-12-31

SeaStar Medical Holding Corporation

SeaStar Medical Holding Corporation logo
Market Cap: Lowest
Employees: Lowest

extracorporeal therapies

Sea Star Medical Holding Corporation is a medical device company focused on novel solutions for treating hyperinflammation and cytokine storm in critically ill patients, specializing in extracorporeal therapies targeting effector cells to manage systemic inflammation.

Tags: cytokine storm, extracorporeal therapies, healthcare, hyperinflammation, immunomodulation, medical device

Symbol: ICU

Recent Price: $2.00

Industry: Biotechnology

CEO: Mr. Eric Schlorff

Sector: Healthcare

Employees: 12

Address: 3513 Brighton Boulevard, Denver, CO 80216

Phone: 844 427 8100

Last updated: 2024-12-31

Statera Biopharma, Inc.

Statera Biopharma, Inc. logo
Market Cap: Lowest
Employees: Lowest

STAT-201, Entolimod, STAT-401, STAT-205

Statera Bio Pharma, Inc. is a clinical-stage biopharmaceutical company focused on developing novel immunotherapies to treat autoimmune diseases, cancers, and infectious diseases by rebalancing the immune system.

Tags: autoimmune, biopharmaceutical, cancer, immune system, immunotherapy, infectious diseases, novel therapies

Symbol: STAB

Recent Price: $0.00

Industry: Biotechnology

CEO: Mr. Michael Kevin Handley

Sector: Healthcare

Employees: 46

Address: 2537 Research Boulevard, Fort Collins, CO 80526

Phone: 888 613 8802

Last updated: 2024-12-31

Vera Therapeutics, Inc.

Vera Therapeutics, Inc. logo
Market Cap: High
Employees: Low

atacicept

Vera Therapeutics, Inc. is a clinical stage biotechnology company focusing on developing and commercializing treatments for serious immunological diseases, including atacicept for immunoglobulin A nephropathy and MAU868 for BK viremia infections.

Tags: MAU868, atacicept, biotechnology, clinical trial, immunological diseases

Symbol: VERA

Recent Price: $42.06

Industry: Biotechnology

CEO: Dr. Marshall W. Fordyce M.D.

Sector: Healthcare

Employees: 72

Address: 8000 Marina Boulevard, Brisbane, CA 94005

Phone: 650 770 0077

Last updated: 2024-12-31

Windtree Therapeutics, Inc.

Windtree Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

istaroxime

Windtree Therapeutics, Inc. is a clinical-stage biopharmaceutical company focusing on developing therapeutics for acute cardiovascular and pulmonary diseases. Their lead programs include treatments for heart failure, respiratory distress, and genetically associated hypertension.

Tags: biopharmaceutical, cardiovascular diseases, clinical trials, heart failure, pulmonary diseases, respiratory distress, therapeutics

Symbol: WINT

Recent Price: $0.31

Industry: Biotechnology

CEO: Mr. Craig E. Fraser

Sector: Healthcare

Employees: 20

Address: 2600 Kelly Road, Warrington, PA 18976-3622

Phone: 215 488 9300

Last updated: 2024-12-31

Atossa Therapeutics, Inc.

Atossa Therapeutics, Inc. logo
Market Cap: Low
Employees: Lowest

Endoxifen

Atossa Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing medicines for oncology and infectious diseases with key programs in breast cancer and COVID-19 treatment.

Tags: COVID-19, Endoxifen, biopharmaceutical, breast cancer, infectious diseases, oncology

Symbol: ATOS

Recent Price: $0.97

Industry: Biotechnology

CEO: Dr. Steven C. Quay FCAP, M.D., Ph.D.

Sector: Healthcare

Employees: 12

Address: 107 Spring Street, Seattle, WA 98104

Phone: 206 588 0256

Last updated: 2024-12-31

Atara Biotherapeutics, Inc.

Atara Biotherapeutics, Inc. logo
Market Cap: Lowest
Employees: Low

T-cell immunotherapy treatments

Atara Biotherapeutics, Inc. is a company focused on developing off-the-shelf T-cell immunotherapy treatments for patients with cancer, autoimmune, and viral diseases, including tabelecleucel for EBV driven diseases, next-generation CAR T therapies, and the ATA368 program for HPV associated cancers.

Tags: Autoimmune Diseases, Biotherapeutics, Cancer Treatment, Immunotherapy, T-Cell Therapy, Viral Diseases

Symbol: ATRA

Recent Price: $13.28

Industry: Biotechnology

CEO: Dr. Anhco Nguyen Ph.D.

Sector: Healthcare

Employees: 165

Address: 611 Gateway Boulevard, South San Francisco, CA 94080

Phone: 650 278 8930

Last updated: 2024-12-31

Astria Therapeutics, Inc.

Astria Therapeutics, Inc. logo
Market Cap: Medium
Employees: Lowest

STAR-0215

Astria Therapeutics, Inc., is a biopharmaceutical company that focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic and immunological diseases in the United States. Its lead product candidate, STAR-0215, is targeting hereditary angioedema.

Tags: allergic diseases, biopharmaceutical, hereditary angioedema, immunological diseases, rare diseases

Symbol: ATXS

Recent Price: $8.88

Industry: Biotechnology

CEO: Ms. Jill C. Milne Ph.D.

Sector: Healthcare

Employees: 59

Address: 100 High Street, Boston, MA 02110

Phone: 617 349 1971

Last updated: 2024-12-31

Axsome Therapeutics, Inc.

Axsome Therapeutics, Inc. logo
Market Cap: High
Employees: Medium

AXS-05, AXS-07, AXS-12, AXS-14

Axsome Therapeutics, Inc. is a biopharmaceutical company focused on developing novel therapies for central nervous system disorders such as major depressive disorder, migraine, narcolepsy, and fibromyalgia.

Tags: CNS disorders, biopharmaceutical, clinical trials, depression, fibromyalgia, migraine, narcolepsy

Symbol: AXSM

Recent Price: $84.78

Industry: Biotechnology

CEO: Dr. Herriot Tabuteau M.D.

Sector: Healthcare

Employees: 589

Address: 22 Cortlandt Street, New York, NY 10007

Phone: 212 332 3241

Leadership

  • Herriot Tabuteau, MD, CHIEF EXECUTIVE OFFICER
  • Nick Pizzie, CPA, MBA, CHIEF FINANCIAL OFFICER
  • Mark Jacobson, MA, CHIEF OPERATING OFFICER
  • Hunter Murdock, Esq., GENERAL COUNSEL
  • ari Maizel, Executive Vice President, Head of Commercial
  • Mark Coleman, MD, DIRECTOR
  • Roger Jeffs, PhD, DIRECTOR
  • Susan Mahony, PhD, MBA, DIRECTOR
  • Mark Saad, DIRECTOR

Last updated: 2024-12-31

Biora Therapeutics, Inc.

Biora Therapeutics, Inc. logo
Market Cap: Lowest
Employees: Lowest

oral biotherapeutics

Biora Therapeutics, Inc., a biotechnology company, focuses on developing oral biotherapeutics using ingestible smart capsules for targeted delivery in the gastrointestinal tract and needle-free delivery into the intestinal mucosa.

Tags: GI diseases, biotechnology, diagnostics, inflammatory bowel diseases, oral biotherapeutics, systemic uptake

Symbol: BIOR

Recent Price: $0.22

Industry: Biotechnology

CEO: Mr. Aditya P. Mohanty M.B.A.

Sector: Healthcare

Employees: 58

Address: 4330 La Jolla Village Drive, San Diego, CA 92122

Phone: 855 293 2639

Leadership

  • Adi Mohanty, MBA, Chief Executive Officer & Board Member
  • Eric d’Esparbes, Chief Financial Officer
  • Robyn Hatton, Head of Human Resources
  • Ariella Kelman, MD, Chief Medical Officer
  • James Knight, MBA, Head of Business Development
  • Clarke Neumann, JD, General Counsel and Secretary
  • Paul Shabram, MBA, Head of Technical Operations
  • Sharat Singh, PhD, Head of Research
  • Maria (Mimi) Villanueva CPMI, PPMC, Vice President, Product Development Operations & Program Management
  • Jeffrey Alter, MBA, Board Chair
  • Jeffrey Ferrell, Board Member
  • Jill Howe, Board Member
  • Brian Kotzin, MD, Board Member
  • Lynne Powell, MBA, Board Member
  • Bruce Sands, MD, MS, Advisory Board Chair
  • Geert D’Haens, MD, PhD, Advisory Board Member
  • Brian Feagan, MD, FRCPC, Advisory Board Member
  • Séverine Vermeire, MD, PhD, Advisory Board Member
  • Satish Rao, MD, PhD, Advisory Board Chair
  • William Chey, MD, Advisory Board Member
  • Anthony Lembo, MD, Advisory Board Member
  • Mark Pimentel, MD, Advisory Board Member

Last updated: 2024-12-31

Estrella Immunopharma, Inc.

Estrella Immunopharma, Inc. logo
Market Cap: Lowest
Employees: Not Available

EB103, EB104

Estrella Immunopharma, Inc. is a preclinical-stage biopharmaceutical company that develops T-cell therapies for blood cancers and solid tumors, with product candidates such as EB103 and EB104. It collaborates with Imugene Limited to develop solid tumor treatments.

Tags: EB103, EB104, Imugene Limited, T-cell therapies, biopharmaceutical, blood cancer, clinical trial, collaboration, solid tumors

Symbol: ESLA

Recent Price: $1.24

Industry: Biotechnology

CEO: Dr. Cheng Liu Ph.D.

Sector: Healthcare

Employees: N/A

Address: 5858 Horton Street, EmeryVille, CA 94608

Phone: 510 318 9098

Last updated: 2024-12-31

Jasper Therapeutics, Inc.

Jasper Therapeutics, Inc. logo
Market Cap: Low
Employees: Lowest

JSP191

Jasper Therapeutics, Inc. is a clinical-stage biotechnology company developing therapeutic agents for hematopoietic stem cell transplantation and gene therapies. Its lead product candidate JSP191 is in clinical development for clearing hematopoietic stem cells from bone marrow in patients prior to transplantation.

Tags: biotechnology, conditioning agents, gene therapies, stem cell engineering, stem cell transplantation

Symbol: JSPR

Recent Price: $20.95

Industry: Biotechnology

CEO: Mr. Ronald A. Martell

Sector: Healthcare

Employees: 45

Address: 2200 Bridge Pkwy, Redwood City, CA 94065

Phone: 650 549 1400

Last updated: 2024-12-31

Intellia Therapeutics, Inc.

Intellia Therapeutics, Inc. logo
Market Cap: High
Employees: Medium

NTLA-2001, NTLA-2002, NTLA-5001

Intellia Therapeutics, Inc. is a genome editing company specializing in developing therapeutics, with a focus on in vivo and ex vivo programs, including treatments for transthyretin amyloidosis, hereditary angioedema, and acute myeloid leukemia. The company also develops engineered cell therapies and offers CRISPR/Cas9 tools.

Tags: CRISPR, autoimmune disorders, ex vivo, genome editing, in vivo, oncology, therapeutics

Symbol: NTLA

Recent Price: $11.41

Industry: Biotechnology

CEO: Dr. John M. Leonard M.D.

Sector: Healthcare

Employees: 526

Address: 40 Erie Street, Cambridge, MA 02139

Phone: 857 285 6200

Last updated: 2024-12-31

Phio Pharmaceuticals Corp.

Phio Pharmaceuticals Corp. logo
Market Cap: Lowest
Employees: Lowest

INTASYL therapeutic platform

Phio Pharmaceuticals Corp. develops immuno-oncology therapeutics using its INTASYL therapeutic platform to target tumor and immune cells by regulating genes of the immune system, focusing on products like PH-762, PH-894, and PH-804 for enhancing cancer immunotherapies in adoptive cell transfer.

Tags: ACT, BRD4, Biotechnology, Cancer, Immuno-Oncology, PD-1, TIGIT, Therapeutics

Symbol: PHIO

Recent Price: $1.90

Industry: Biotechnology

CEO: Mr. Robert J. Bitterman

Sector: Healthcare

Employees: 8

Address: 257 Simarano Drive, Marlborough, MA 01752

Phone: 508 767 3861

Last updated: 2024-12-31

Verastem, Inc.

Verastem, Inc. logo
Market Cap: Low
Employees: Low

VS-6766

Verastem, Inc. is a biopharmaceutical company focused on developing and commercializing drugs for cancer treatment, with products such as VS-6766 and trials like RAMP 201 and 202 targeting various cancer types.

Tags: MEK, RAF, RAMP 201, RAMP 202, VS-6766, biopharmaceutical, cancer treatment, drug development

Symbol: VSTM

Recent Price: $3.67

Industry: Biotechnology

CEO: Mr. Daniel W. Paterson

Sector: Healthcare

Employees: 73

Address: 117 Kendrick Street, Needham, MA 02494

Phone: 781 292 4200

Last updated: 2024-12-31

Abeona Therapeutics Inc.

Abeona Therapeutics Inc. logo
Market Cap: Low
Employees: Low

EB-101

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa.

Tags: EB-101, biopharmaceutical, cell therapy, clinical trials, gene therapy, rare genetic diseases

Symbol: ABEO

Recent Price: $5.61

Industry: Biotechnology

CEO: Dr. Vishwas Seshadri M.B.A., Ph.D.

Sector: Healthcare

Employees: 84

Address: 1330 Avenue of the Americas, New York, NY 10019

Phone: 646 813 4701

Last updated: 2024-12-31

Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals, Inc. logo
Market Cap: Medium
Employees: Low

TERN-101, TERN-201, TERN-501, TERN-601

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing small-molecule therapies for non-alcoholic steatohepatitis (NASH) and obesity, incorporating products like TERN-101, TERN-201, TERN-501, and TERN-601.

Tags: NASH, biopharmaceutical, clinical trials, obesity, pharmaceutical research

Symbol: TERN

Recent Price: $7.15

Industry: Biotechnology

CEO: Ms. Amy L. Burroughs M.B.A.

Sector: Healthcare

Employees: 66

Address: 1065 East Hillsdale Boulevard, Foster City, CA 94404

Phone: 650 525 5535

Last updated: 2024-11-08